PPT-Statin Adherence Purpose

Outline the issue of medication nonadherence and reasons that patients may not adhere to medications with a particular focus on statin Review strategies to improve patient adherence to statins 2. Jackevicius BScPhm MSc FCSHP Muhammad Mamdani PharmD MA MPH Jack V Tu MD PhD FRCPC TATINS 3 HYDROXY 3 METHYL glutaryl coenzyme A HMG CoA reductase inhibitors have been shown to significantly re duce morbidity and mortality in pa tients with coronary Meck Chongo, . Virginia . Russell, . Josée. Lavoie, Ross Hoffman, . Mamdouh. . Shubair. University of Northern British Columbia. Agenda. . Background. Objectives . Participants & Research Environment. Louis H. Stein, Jessica Berger, Maryann . Tranquilli. , . John A. . Elefteriades. .. . The Aortic Institute at Yale – New Haven Hospital . Bench top to bedside interaction. . Medial Degeneration . Canadian Consensus . Working Group Update (2016). G.B. John Mancini, MD, Steven Baker, MD, Jean Bergeron, MD, David Fitchett, MD, . Jiri Frohlich, MD, Jacques Genest, MD, Milan Gupta, MD, Robert A. Hegele, MD, . . U. nderstanding . S. tatin Use in . A. merica and . G. aps in . E. ducation. The Largest Known Cholesterol Survey . Conducted in the U.S. . USAGE Survey Rationale—I . Lack of adherence & persistence of statin therapy is a common problem. Under-Representation of Women . in Clinical Trials. CVD in Women. Women. ’. s CV Risk is Often Misunderstood or Misdiagnosed. Gender Disparities in Screening, Diagnosis, and Treatment of Dyslipidemia. Thomas Delate, PhD, MS. Clinical Pharmacy Research Scientist. Kaiser Permanente Colorado. What to Expect Today. Review . biostatistic. . principles. Hands on application. Questions related to your research project. . CareMesssage. . trial. a . convenience. sample . of. COPD . patients. . assigned. . to. . the. . COPD Access . To. Community . Health. (CATCH) . were. . recruited. . to. . participate. Diagnosis, Prevention and Management of Statin Adverse Effects and Intolerance: Canadian Consensus Working Group Update (2016) G.B. John Mancini, MD, Steven Baker, MD, Jean Bergeron, MD, David Fitchett, MD, Control. Relative risk. Absolute Effect. (per thousand). Statin. Myalgia. 348/14960. (2.3%) . 288/14520. (2.0%). 1.02. (0.88-1.19). +1. (-1 to +5). Rhabdomyolysis. 138/2454. (5.6%). 158/2446. (6.5%). . Rabizadeh. , . MD. .. Imam . Khomeini . Medical . Complex,. Tehran . University of Medical Sciences. Introduction. Statin . use has . increased progressively in all age groups since . 1988 . The . of the NLA. Conclusions of the NLA Safety Task Force for Muscle Safety. Myopathy and rhabdomyolysis are associated with statin therapy, as a class effect. Elevated creatine kinase (CK) levels may indicate statin-induced muscle damage. Alfred Fisher MD PhD. Professor and Chief. Division of Geriatrics, Gerontology,. and Palliative Medicine. University of Nebraska Medical Center. Older Patients in Primary Care often take Statins. Johansen, et. al. . Slide deck. The full text of the paper is available at. http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(18)31652-0/fulltext. . Rationale. Lipoprotein. (a) . is. an . established. . risk.